Stoke Therapeutics, Inc. (0GT.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 08:00AM CEST
| Previous Close | 11.00 |
| Open | 10.60 |
| Bid | 10.90 x N/A |
| Ask | 11.00 x N/A |
| Day's Range | 10.60 - 10.60 |
| 52 Week Range | 3.16 - 13.00 |
| Volume | |
| Avg. Volume | 21 |
| Market Cap | 552.471M |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.25 |
| Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 62.88 |
GuruFocus.comStoke Therapeutics Inc (STOK) Reports Q1 2024 Financial Results: A Closer Look at Challenges ...
Despite Narrow Miss on EPS, Stoke Therapeutics Advances in Clinical Developments
Simply Wall St.Stoke Therapeutics First Quarter 2024 Earnings: Beats Expectations
Stoke Therapeutics ( NASDAQ:STOK ) First Quarter 2024 Results Key Financial Results Net loss: US$26.4m (loss widened by...
ZacksStoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
Stoke Therapeutics (STOK) delivered earnings and revenue surprises of 5% and 26.61%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.